Press Releases

  • New Sparta Solution Helps Companies Comply with FDA UDI Ruling

    HAMILTON, N.J. – September 23, 2013 –Sparta Systems, Inc., an industry pioneer and global leader in enterprise quality management software (EQMS) solutions, announced today the release of TrackWise® UDI eSubmission Manager.  TrackWise is the company’s award winning EQMS that is used by leading medical device companies for complaint handling, adverse event reporting, non-conformance investigation, Corrective Action/Preventive Action (CAPA), registration tracking, and other quality and regulatory processes.  The release marks Sparta’s fifth supported electronic reporting standard which includes support for eMDR and eMDV electronic submission processes.

    The new FDA ruling calls for labelers to submit product information concerning medical devices to FDA’s Global Unique Device Identification Database (GUDID), unless they are subject to an exception.  Specifically, it requires that product registration data is packaged and submitted to GUDID using XML transport and delivery.  The TrackWise UDI eSubmission Manager performs this packaging and transmission to the GUDID gateway. Once the GUDID gateway receives the information, it sends back an acknowledgement which is tracked as an integrated part of the workflow. This provides the traceability for the initial UDI registration. Any subsequent product change, initiated through TrackWise Change Control process is handled the same way, effectively maintaining the history of UDI updates as required by regulation.

    In addition to handling UDI product information submission, Sparta Systems recognizes the wide range of impact the newly required standard will have, and is already working consultatively with medical device and combination products companies to understand and make the required changes to their quality processes and systems.

    “Our close, strategic relationship with many of the leading medical device companies allowed us to proactively build this product in advance of the final ruling from the FDA,” said Mike Jovanis, Sparta Systems’ Vice President of Product Management and Strategy.  “We are proud to deliver an immediate solution to our customers that will not only help them comply with the new ruling, but also allow them to quickly begin implementation given the narrow window mandated by the FDA.”

    The full FDA ruling can be found at https://s3.amazonaws.com/public-inspection.federalregister.gov/2013-23059.pdf.


    About Sparta Systems

    Founded in 1994, Sparta Systems is the world’s premier provider of cloud and on-premise quality management software. We offer the solutions, analytics, and expertise that speed up quality and compliance. Our solutions help to lower risk, increase efficiency, and keep consumers safe while allowing manufacturers, suppliers, and distributors to collaborate in a seamless and integrated environment. Sparta is privately owned and headquartered in Hamilton N.J, with offices across Europe and Asia. We support close to 1 million users across 700+ implementations, in more than 30 countries. Companies in life sciences, consumer products, discrete manufacturing and more, rely on Sparta.

 
© 1995-2017 Sparta Systems, Inc. All Rights Reserved.
© 1995-2017 Sparta Systems, Inc. All Rights Reserved.Sparta Systems Logo